Use of prostaglandin (pge2) receptor 4 (ep4) selective...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/41 (2006.01) A61K 31/00 (2006.01) A61K 31/4015 (2006.01) A61P 13/12 (2006.01)

Patent

CA 2332687

This invention is directed to pharmaceutical compositions for treating acute or chronic renal failure or dysfunction, or conditions caused thereby, comprising prostaglandin agonists, which are EP4 receptor selective prostaglandin agonists, in admixture with pharmaceutically acceptable carriers or diluents.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of prostaglandin (pge2) receptor 4 (ep4) selective... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of prostaglandin (pge2) receptor 4 (ep4) selective..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of prostaglandin (pge2) receptor 4 (ep4) selective... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1356567

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.